Philip C. Amrein, MD
Assistant Professor, Department of Medicine, Harvard Medical School
Physician, Medicine Service, Massachusetts General Hospital
Contact Info
Philip Amrein
Massachusetts General Hospital
Hemotology-Oncology, Cox 664
Boston, MA, 02114
Phone: 617-726-8748
Fax: 617-724-3166
pamrein@partners.org
Massachusetts General Hospital
Hemotology-Oncology, Cox 664
Boston, MA, 02114
Phone: 617-726-8748
Fax: 617-724-3166
pamrein@partners.org
Assistant
Not Available.DF/HCC Program Affiliation
Lymphoma and MyelomaLeukemia
Research Abstract
My research focus has been in the treatment of patients with acute and chronic leukemia. I have also participated in clinical trials for patients with myelodysplasia and multiple myeloma. The following is a list of clinical trials that I am most interested in accruing patients to:1) DF/HCC protocol 06-254, which tests a new sequence of drugs for acute lymphoid leukemia
2) DF/HCC protocol 05-308 and CALGB 10303, which compares the effectiveness of dasatinib to standard therapy imatinib for CML in chronic phase
3) CALGB 10502, which tests the addition of bortezomib to standard treatment in acute myeloid leukemia
4) DF/HCC protocol 06-211, which tests the effectiveness of dasatinib in relapsed chronic lymphocytic leukemia
